The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_001130987.2(DYSF):c.5953_5956del (p.Gln1985fs)

CA222196

94347 (ClinVar)

Gene: DYSF
Condition: autosomal recessive limb-girdle muscular dystrophy
Inheritance Mode: Autosomal recessive inheritance
UUID: e3ed8dda-b353-4e3b-a891-565f325d11a6
Approved on: 2025-01-08
Published on: 2025-01-08

HGVS expressions

NM_001130987.2:c.5953_5956del
NM_001130987.2(DYSF):c.5953_5956del (p.Gln1985fs)
NC_000002.12:g.71679125_71679128del
CM000664.2:g.71679125_71679128del
NC_000002.11:g.71906255_71906258del
CM000664.1:g.71906255_71906258del
NC_000002.10:g.71759763_71759766del
NG_008694.1:g.230503_230506del
ENST00000698057.1:c.3367_3370del
ENST00000698058.1:c.2584_2587del
ENST00000698059.1:c.2692_2695del
ENST00000258104.8:c.5836_5839del
ENST00000410020.8:c.5953_5956del
ENST00000258104.7:c.5836_5839del
ENST00000394120.6:c.5839_5842del
ENST00000409366.5:c.5902_5905del
ENST00000409582.7:c.5950_5953del
ENST00000409651.5:c.5932_5935del
ENST00000409744.5:c.5860_5863del
ENST00000409762.5:c.5887_5890del
ENST00000410020.7:c.5953_5956del
ENST00000410041.1:c.5890_5893del
ENST00000413539.6:c.5929_5932del
ENST00000429174.6:c.5899_5902del
ENST00000479049.6:n.2721_2724del
NM_001130455.1:c.5839_5842del
NM_001130976.1:c.5794_5797del
NM_001130977.1:c.5857_5860del
NM_001130978.1:c.5899_5902del
NM_001130979.1:c.5929_5932del
NM_001130980.1:c.5887_5890del
NM_001130981.1:c.5950_5953del
NM_001130982.1:c.5932_5935del
NM_001130983.1:c.5902_5905del
NM_001130984.1:c.5860_5863del
NM_001130985.1:c.5890_5893del
NM_001130986.1:c.5797_5800del
NM_001130987.1:c.5953_5956del
NM_003494.3:c.5836_5839del
NM_001130455.2:c.5839_5842del
NM_001130976.2:c.5794_5797del
NM_001130977.2:c.5857_5860del
NM_001130978.2:c.5899_5902del
NM_001130979.2:c.5929_5932del
NM_001130980.2:c.5887_5890del
NM_001130981.2:c.5950_5953del
NM_001130982.2:c.5932_5935del
NM_001130983.2:c.5902_5905del
NM_001130984.2:c.5860_5863del
NM_001130985.2:c.5890_5893del
NM_001130986.2:c.5797_5800del
NM_003494.4:c.5836_5839del
More

Pathogenic

Met criteria codes 4
PP4_Strong PM3_Supporting PP1 PVS1
Not Met criteria codes 1
PM2

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Limb Girdle Muscular Dystrophy Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for DYSF Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Limb Girdle Muscular Dystrophy VCEP
The NM_003494.4: c.5836_5839del p.(Gln1946TrpfsTer19) variant in DYSF, which is also known as NM_001130987.2: c.5953_5956del p.(Gln1985TrpfsTer19)), is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 52/55, leading to nonsense mediated decay in a gene in which loss of function is an established disease mechanism (PVS1). This variant has been detected in at least 3 unrelated individuals with limb girdle muscular dystrophy (PMID: 30564623, 19528035), including in unknown phase with a pathogenic variant (c.1852G>C p.(Gly618Arg), 0.5 pt, PMID: 30564623) (PM3_Supporting). At least one patient with this variant displayed progressive limb girdle muscle weakness and absent dysferlin protein expression, which is highly specific for DYSF-associated LGMD (PP4_Strong, PMID: 19528035, 30564623). The variant was also reported to co-segregate with the disease in one affected family member (PMID: 19528035) (PP1). The filtering allele frequency of the variant is 0.000114 for European (non-Finnish) genome alleles in gnomAD v3.1.2 (the upper threshold of the 95% CI of 3/68008), which is greater than the LGMD VCEP threshold (<0.0001) for PM2_Supporting (criterion not met). In summary, this variant meets the criteria to be classified as Pathogenic for autosomal recessive limb girdle muscular dystrophy based on the ACMG/AMP criteria applied, as specified by the ClinGen LGMD VCEP (LGMD VCEP specifications version 1.0.0; 01/08/2025): PVS1, PM3_Supporting, PP4_Strong, PP1.
Met criteria codes
PP4_Strong
At least one patient with this variant displayed progressive limb-girdle muscle weakness and absent dysferlin protein expression, which is highly specific for DYSF-associated LGMD (PP4_Strong, PMID: 19528035, 30564623).
PM3_Supporting
This variant has been detected in at least 3 unrelated individuals with limb girdle muscular dystrophy (PMID: 30564623, 19528035). Of those, the variant was identified in unknown phase with a pathogenic variant (c.1852G>C p.(Gly618Arg), 0.5 pt, PMID: 30564623) (PM3_Supporting).
PP1
The variant was also reported to co-segregate with the disease in 1 affected family member (PMID: 19528035) (PP1).
PVS1
The NM_003494.4: c.5836_5839del p.(Gln1946TrpfsTer19) variant in DYSF, which is also known as NM_001130987.2: c.5953_5956del p.(Gln1985TrpfsTer19)), is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 52/55 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1).
Not Met criteria codes
PM2
The filtering allele frequency of the variant is 0.000114 for European (non-Finnish) genome alleles in gnomAD v3.1.2 (the upper threshold of the 95% CI of 3/68008), which is greater than the LGMD VCEP threshold (<0.0001) for PM2_Supporting (criterion not met).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.